Publications by authors named "Jan Verner"

Claim this Profile
C
Creatine kinase B, a downstream effector of c-Myb, controls migration of osteosarcoma cells via regulation of N-cadherin.
Jana Pokludová, Petr Lapčík, Iva Staniczková Zambo, Jiří Kohoutek, Danica Zapletalová, Jan Verner

Cancer Cell Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.
Eva Hoferkova, Vaclav Seda, Sona Kadakova, Jan Verner, Tomas Loja

Leukemia· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factor c-Myb: novel prognostic factor in osteosarcoma.
Kamila Říhová, Monika Dúcka, Iva Staniczková Zambo, Ladislava Vymětalová, Martin Šrámek, Jan Verner

Clin Exp Metastasis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia.
Vaclav Seda, Eva Vojackova, Laura Ondrisova, Lenka Kostalova, Sonali Sharma, Jan Verner

Blood· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro.
Aneta Ledererova, Lenka Dostalova, Veronika Kozlova, Helena Peschelova, Adriana Ladungova, Jan Verner

J Immunother Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia.
Veronika Mancikova, Helena Peschelova, Veronika Kozlova, Aneta Ledererova, Adriana Ladungova, Jan Verner

J Immunother Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells.
Miroslav Boudny, Jana Zemanova, Prashant Khirsariya, Marek Borsky, Jan Verner

Haematologica· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
Pavlina Janovska, Jan Verner, Jiri Kohoutek, Lenka Bryjova, Michaela Gregorova

Blood· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines.
Jan Verner, Martin Trbusek, Jana Chovancova, Zuzana Jaskova, Mojmir Moulis

Leuk Lymphoma· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells.
Jana Zemanova, Ondrej Hylse, Jana Collakova, Pavel Vesely, Alexandra Oltova, Jan Verner

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration.
Markéta Kaucká, Karla Plevová, Sárka Pavlová, Pavlína Janovská, Archana Mishra, Jan Verner

Cancer Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of acute graft-vs-host disease after hematopoietic stem cell transplantation.
Jan Verner, Jitka Kabathova, Alexandra Tomancova, Sarka Pavlova, Boris Tichy

Exp Hematol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential biomarkers for early detection of acute graft-versus-host disease.
Gabriela Lochmanová, Lenka Jedličková, David Potěšil, Alexandra Tomancová, Jan Verner

Proteomics Clin Appl· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia.
Marek Mraz, Dasa Dolezalova, Karla Plevova, Katerina Stano Kozubik, Veronika Mayerova, Jan Verner

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human embryonic stem cells are capable of executing G1/S checkpoint activation.
Tomás Bárta, Vladimír Vinarský, Zuzana Holubcová, Dása Dolezalová, Jan Verner

Stem Cells· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis